Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC3242297489;97490;97491 chr2:178542492;178542491;178542490chr2:179407219;179407218;179407217
N2AB3078192566;92567;92568 chr2:178542492;178542491;178542490chr2:179407219;179407218;179407217
N2A2985489785;89786;89787 chr2:178542492;178542491;178542490chr2:179407219;179407218;179407217
N2B2335770294;70295;70296 chr2:178542492;178542491;178542490chr2:179407219;179407218;179407217
Novex-12348270669;70670;70671 chr2:178542492;178542491;178542490chr2:179407219;179407218;179407217
Novex-22354970870;70871;70872 chr2:178542492;178542491;178542490chr2:179407219;179407218;179407217
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: E
  • RefSeq wild type transcript codon: GAA
  • RefSeq wild type template codon: CTT
  • Domain: Fn3-124
  • Domain position: 24
  • Structural Position: 25
  • Q(SASA): 0.3833
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
E/K rs1695041603 None 0.124 N 0.605 0.183 0.224531998449 gnomAD-3.1.2 6.57E-06 None None None None N None 2.41E-05 0 0 0 0 None 0 0 0 0 0
E/K rs1695041603 None 0.124 N 0.605 0.183 0.224531998449 gnomAD-4.0.0 6.57488E-06 None None None None N None 2.41464E-05 0 None 0 0 None 0 0 0 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
E/A 0.0995 likely_benign 0.1002 benign -0.706 Destabilizing 0.124 N 0.666 neutral N 0.469371003 None None N
E/C 0.6206 likely_pathogenic 0.5916 pathogenic -0.285 Destabilizing 0.968 D 0.769 deleterious None None None None N
E/D 0.0764 likely_benign 0.0763 benign -0.804 Destabilizing 0.001 N 0.264 neutral N 0.472247867 None None N
E/F 0.5508 ambiguous 0.4964 ambiguous -0.265 Destabilizing 0.89 D 0.768 deleterious None None None None N
E/G 0.0924 likely_benign 0.0929 benign -1.02 Destabilizing 0.001 N 0.407 neutral N 0.516636149 None None N
E/H 0.3126 likely_benign 0.2752 benign -0.388 Destabilizing 0.726 D 0.621 neutral None None None None N
E/I 0.2525 likely_benign 0.2244 benign 0.13 Stabilizing 0.726 D 0.774 deleterious None None None None N
E/K 0.124 likely_benign 0.1084 benign -0.221 Destabilizing 0.124 N 0.605 neutral N 0.462857592 None None N
E/L 0.1862 likely_benign 0.1766 benign 0.13 Stabilizing 0.567 D 0.738 prob.delet. None None None None N
E/M 0.2617 likely_benign 0.2455 benign 0.44 Stabilizing 0.909 D 0.771 deleterious None None None None N
E/N 0.1123 likely_benign 0.1121 benign -0.682 Destabilizing 0.272 N 0.615 neutral None None None None N
E/P 0.6714 likely_pathogenic 0.6713 pathogenic -0.127 Destabilizing 0.726 D 0.753 deleterious None None None None N
E/Q 0.1032 likely_benign 0.0958 benign -0.579 Destabilizing 0.009 N 0.259 neutral N 0.466052613 None None N
E/R 0.2247 likely_benign 0.1945 benign 0.042 Stabilizing 0.396 N 0.625 neutral None None None None N
E/S 0.1154 likely_benign 0.1149 benign -0.914 Destabilizing 0.157 N 0.587 neutral None None None None N
E/T 0.1568 likely_benign 0.1508 benign -0.655 Destabilizing 0.567 D 0.721 prob.delet. None None None None N
E/V 0.1661 likely_benign 0.1474 benign -0.127 Destabilizing 0.497 N 0.741 deleterious N 0.478525262 None None N
E/W 0.8224 likely_pathogenic 0.7696 pathogenic -0.015 Destabilizing 0.968 D 0.761 deleterious None None None None N
E/Y 0.4025 ambiguous 0.3519 ambiguous -0.007 Destabilizing 0.89 D 0.786 deleterious None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.